Our Technology Platform

Therapeutic medical gases have the potential to address a wide spectrum of diseases, but have been limited by inhaled delivery, which for conscious patients is inaccurate in dosing, potentially unsafe, and highly intrusive.

Hillhurst’s GLASS technology platform is designed to address the challenges of inhaled therapeutics by enabling liquid delivery of these agents in a form that ensures accurate dosing, without risk of unwanted inhalation or environmental contamination.

With our GLASS platform, we create liquid drug products containing appropriate concentrations of the targeted medical agent, with uptake through the gastrointestinal system. Combining known medical gases with our proprietary technology, we produce novel liquid medicines designed to effectively and accurately deliver therapeutic molecules, expanding the clinical applications of this important class of medication.